Clinical Trials for Drug: VRx3996

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-17-47 A Phase 1b/2 Open-Label, Dose Escalation and Expansion Study of Orally Administered VRx-3996 and Valganciclovir in Subjects with Epstein-Barr Virus-Associated Lymphoid Malignancies Open